Opko Health Inc (OPK) 10.02 $OPK OPKO to Announce Second

New Post Public Reply Private Reply Replies (0) Message Board

Aug 4, 2016 at 3:14 PM

Opko Health Inc (OPK) 10.02 $OPK

OPKO to Announce Second Quarter Operating and Financial Results on August 8, 2016
BusinessWire - Wed Aug 03, 11:14AM CDT
OPKO Health, Inc. (NASDAQ:OPK) will release operating and financial results for the three and six months ended June 30, 2016, after the close of the U.S. financial markets on Monday, August 8, 2016.
OPK: 10.02 (+0.04)

InvestorsObserver releases covered-call reports for OPKO Health, ACADIA Pharmaceuticals, Whiting Petroleum, VMware and Jabil Circuit
PR Newswire - Tue Aug 02, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ACAD, JBL, OPK, VMW, and WLL.
WLL: 7.50 (+0.21), ACAD: 36.89 (-0.28), VMW: 70.45 (+0.05), OPK: 10.02 (+0.04), JBL: 20.25 (+0.15)

Covered Call reports for Bank of America, CSX, Reynolds American Incorporated, Barrick Gold Corporation and Opko Health include trade ideas that offer returns of 20% or more!
PR Newswire - Thu Jul 14, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for ABX, BAC, CSX, OPK, and RAI.
RAI: 48.86 (-0.49), OPK: 10.02 (+0.04), ABX: 22.48 (+0.06), BAC: 14.52 (+0.04), CSX: 28.07 (-0.13)

Opko Health (OPK) Catches Eye: Stock Adds 5.6% in Session
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:15AM CDT
Opko Health, Inc. (OPK) shares rose almost 6% in the last trading session.
OPK: 10.02 (+0.04), CRY: 13.99 (-0.01)

Here's Why Opko Health (OPK) Stock Is Gaining Today
Ryan McQueeney - Zacks Investment Research - Tue Jun 21, 11:31AM CDT
Shares of Opko Health (OPK) are up nearly 5.5% in morning trading Tuesday following the news that the FDA has approved its new treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease.
OPK: 10.02 (+0.04)

Company News for June 21, 2016
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 9:10AM CDT
Companies in the News are: MRO,OPK,DIS,LC
LC: 4.68 (+0.04), OPK: 10.02 (+0.04), DIS: 95.06 (-1.03), MRO: 13.38 (-0.04)

VBI Vaccines Announces Closing of $13.6 Million Private Placement
Marketwire Canada - Tue Jun 21, 7:30AM CDT
CAMBRIDGE, MASSACHUSETTS--(Marketwired - Jun 21, 2016) - VBI Vaccines (NASDAQ:VBIV)(TSX:VBV) ("VBI"

, today announced the closing of an equity private placement financing led by OPKO Health (NYSE:OPK) and Perceptive Advisors, with participation by ARCH Venture Partners. In accordance with Toronto Stock Exchange (TSX) regulations, aggregate participation by certain current investors was limited to 10% of the issued and outstanding common shares in any given 6-month period. As a result, these current investors in VBI participated to their maximum possible allocation.
OPK: 10.02 (+0.04), VBIV: 3.78 (-0.01), VBV.TO: 4.72 (+0.02)

FDA Approves New Drug Application for RAYALDEE(R) to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease
BusinessWire - Tue Jun 21, 1:00AM CDT
--There are Approximately 9 Million Patients in the U.S. with SHPT, Stage 3 or 4 CKD and Vitamin D Insufficiency; Large Potential U.S. Market
OPK: 10.02 (+0.04)

Opko Health Inc Enters Oversold Territory (OPK)
MarketNewsVideo.com - Tue Jun 14, 11:09AM CDT
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative...
OPK: 10.02 (+0.04)

OPKO Health Announces Move to NASDAQ Stock Market
BusinessWire - Mon Jun 13, 8:10AM CDT
OPKO Health, Inc. (NYSE:OPK) ("OPKO" or the "Company"

announces that it will move its stock exchange listing to The NASDAQ Stock Market from The New York Stock Exchange (the "NYSE"

. The Company expects its common stock will begin trading on the NASDAQ Global Select Market ("NASDAQ"

on June 24, 2016, and its shares will continue to trade under the ticker symbol "OPK."
OPK: 10.02 (+0.04)

Covered Call Alerts For Gilead Sciences, Western Digital, Costco, Opko Health and Ulta Salon Cosmetics & Fragrance Inc. Released By InvestorsObserver
PR Newswire - Wed Jun 08, 9:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GILD, WDC, COST, OPK and ULTA.
OPK: 10.02 (+0.04), GILD: 79.78 (-0.31), COST: 166.33 (+0.21), ULTA: 259.94 (+1.03), WDC: 44.45 (-0.33)

OPKO to Discuss Draft Coverage Determinations for 4Kscore(R) Test at 2016 Jefferies Healthcare Conference
BusinessWire - Tue Jun 07, 3:05PM CDT
OPKO Health, Inc. (NYSE: OPK) today announced that senior management will discuss recent draft local coverage determinations by certain Medicare Administrative Contractors for OPKO's 4Kscore(R) test at the Jefferies Healthcare Conference in New York City on Thursday, June 9, 2016 at 11:30 AM (EDT). OPKO previously announced that Novitas Solutions issued a positive draft local coverage determination proposing to establish reimbursement coverage for patients with PSA levels > 3 ng/mL who have not yet had a biopsy, or patients with a PSA level of > 3 ng/mL who have had at least one prior negative biopsy and are considered to be at higher risk. The draft coverage determination was subsequently retired by Novitas due to a potential conflict with another Medicare Administrative Contractor. Palmetto GBA had issued a draft non-coverage determination on May 27th for the 4Kscore test.
OPK: 10.02 (+0.04)

Biotechnology Stocks in Motion -- Celldex Therapeutics, Medivation, Opko Health, and ACADIA Pharma
PR Newswire - Tue Jun 07, 7:05AM CDT
On Monday, June 06, 2016, the NASDAQ Composite ended the trading session at 4,968.71, up 0.53%; the Dow Jones Industrial Average advanced 0.64% to finish at 17,920.33; and the S&P 500 closed at 2,109.41, up 0.49%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Celldex Therapeutics Inc. (NASDAQ: CLDX), Medivation Inc. (NASDAQ: MDVN), Opko Health Inc. (NYSE: OPK), and ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD). Learn more about these stocks by accessing their free trade alerts at:
MDVN: 63.69 (-0.39), ACAD: 36.89 (-0.28), OPK: 10.02 (+0.04), CLDX: 4.58 (-0.08)

OPKO Health to Present at the 2016 Jefferies Healthcare Conference
BusinessWire - Thu Jun 02, 7:47AM CDT
OPKO Health, Inc. (NYSE:OPK) today announced that senior management will present at the Jefferies Healthcare Conference in New York City on Thursday, June 9, 2016 at 11:30 AM (EDT).
OPK: 10.02 (+0.04)

OPKO Health Receives Proposed/Draft Medicare Local Coverage Determination for 4Kscore(R) Test
BusinessWire - Fri May 27, 7:30AM CDT
OPKO Health, Inc. (NYSE:OPK) ("OPKO" or the "Company"

announces that Novitas Solutions has issued a draft local coverage determination for the 4Kscore(R) Test, the only blood test that accurately identifies an individual patient's risk for high-grade, aggressive prostate cancer. Novitas Solutions is a Medicare Administrative Contractor (MAC) for Medicare jurisdictions L and H, with responsibility for nearly 10 million Medicare beneficiaries in New Jersey, Pennsylvania, Maryland, the District of Columbia and Texas, among other geographies.
OPK: 10.02 (+0.04)

Global Vitamin D Deficiency Disorders Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Merck, OPKO Health, DSM Biologics Holdings - Research and Markets
BusinessWire - Fri May 27, 6:57AM CDT
Research and Markets has announced the addition of the "Vitamin D Deficiency Disorders Global Clinical Trials Review, H1, 2016" clinical trials to their offering.
OPK: 10.02 (+0.04), MRK: 57.96 (+0.31)

OPKO Health, Inc. - Product Pipeline Review - 2016 - Research and Markets
BusinessWire - Thu May 26, 4:36PM CDT
Research and Markets has announced the addition of the "OPKO Health, Inc. - Product Pipeline Review - 2016" company profile to their offering.
OPK: 10.02 (+0.04)

Under Armour trade offers a 19% return in 52 days, or find similar option trades on Opko Health, Herbalife, Costco, and Microsoft
PR Newswire - Wed May 25, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for UA, OPK, HLF, COST and MSFT.
UA: 38.93 (+0.02), HLF: 67.16 (+0.12), OPK: 10.02 (+0.04), COST: 166.33 (+0.21), MSFT: 57.46 (+0.49)

Cocrystal Pharma to Present at Jefferies 2016 Healthcare Conference
Marketwired - Wed May 25, 7:01AM CDT
Cocrystal CEO & CMO to Present Thursday, June 9, 2016, 8:30 AM ET in NYC
OPK: 10.02 (+0.04)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wisconsin Chefs Transform Pizza with Crave Brothers Cheese

Reimagining Pizza with Wisconsin's Best Cheeses It's not every day you see a pizza challenge that turns a staple of Friday nights into a gastronomic showcase. But that's exactly what's happening in Wisconsin as chefs flex their creativity using Crave Brothers Farmstead Cheese. This is no ordinary cheese-and-pepperoni affair—these culinary pros are cooking up pizzas with...

Kroger, Imprint Team Up for AI-Driven Mastercard

Kroger Teams Up with Imprint for New Credit Card Kroger’s at it again, folks. They're rolling out a shiny new Mastercard, and it's not just any plastic—it’s powered by the AI-driven platform Imprint. Now, what does this mean for you and me? Well, if you're a frequent flyer at Kroger aisles, you might want to pay attention because this card’s offering point...

MiniCo's New Desk: A Game Changer for E&S Market

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Fiber Giants Unite to Boost Connectivity in Montana

Montana's Broadband Transformation Takes a Leap Folks in Northwest Montana, take note. Vero Fiber and MontanaSky have tied the knot, officially sealing a merger that doesn't just unite two reputable broadband providers but promises to shake up the internet game across the region. Just ask anyone who's tried to stream a movie during peak hours in Flathead Valley. A...

Neutonic Sets Sights on U.S. with Walmart Expansion

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Athlete Threats: Public Info Fuels Security Risks

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Cannatrol and Veterans Nonprofit Unite for Healing

Veterans Find a New Ally in Cannabis Tech When two distinct worlds collide for a cause, it can create waves of change much bigger than simple collaboration. That's exactly what's happening with Cannatrol and Operation Green Healing, a partnership that could redefine support for our veterans. Cannatrol, renowned for its groundbreaking post-harvest cannabis technology, has...

Haystack MRD Shines in Colorectal Cancer Trials

A New Dawn in Cancer Detection Just when you think you've seen it all in cancer diagnostics, Haystack MRD® pops up like a fresh tulip in spring. And listen, this ain't just fluff—the results from the DYNAMIC trials are a pretty compelling love letter to the power of liquid biopsy. With 100% specificity and sensitivity hitting a whopping 83.3% over five years, it’s...

Ace Hardware Ups the Stakes with Rewards Days Event

Ace Hardware: Doubling Down with Rewards Ace Hardware's rolling out the red carpet for its loyal customers. Imagine this: exclusive deals on trusted brands and double points on purchases—an incentive any savvy shopper would jump at. From October 6 to 7, those in the Ace Rewards circle have the chance to nab some hefty savings and perks, a move that's more than just a...